These studies highlight that RAS mutations are frequent at diagnosis (25–73% frequency) in patients carrying KMT2A rearrangements, in particular in pediatric KMT2A-AFF1 cases, and that these mutations can be either clonal or subclonal secondary genetic events that might take part of a delicate selection process underlying clonal evolution of leukemia. The gene discussed is AFF1; the disease is leukemia.